We offer several GLP-1-based therapies, prescribed individually depending on your health profile, weight loss goals, insurance coverage, and personal preferences
And we think these are a good option if you want to schedule specific doses
In contrast, metabolic disorders and disorders related to dysfunctions in reward processing (i.e., major depressive disorder and substance use disorders) have received less attention to date
Key Considerations for GLP-1 Patients GLP-1 receptor agonists like semaglutide and tirzepatide are changing how we approach weight management and metabolic health
JastreboffAMAronneLJAhmadNNWhartonSConneryLAlvesBet al
In respect to their cardiovascular effects among patients with T2DM, both GLP-1RAs and SGLT2is have been shown to reduce the risk of MACE (cardiovascular death, non-fatal myocardial infarction, or non-fatal stroke), with GLP-1RAs reducing the risk of non-fatal stroke to a greater extent [3, 6]